0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Levamisole Hydrochloride Tablets Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-33F11881
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Levamisole Hydrochloride Tablets Market Research Report 2022
BUY CHAPTERS

Global Levamisole Hydrochloride Tablets Market Research Report 2024

Code: QYRE-Auto-33F11881
Report
June 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Levamisole Hydrochloride Tablets Market

The global Levamisole Hydrochloride Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Levamisole Hydrochloride Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Levamisole Hydrochloride Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Levamisole Hydrochloride Tablets include Nanjing Baijingyu Pharmaceutical, Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical, Zhejiang Ruixin Pharmaceutical, Guangdong Huanan Pharmaceutical, Guilin Pharmaceutical, Shanxi Taiyuan Pharmaceutical, Guangdong Nanguo Pharmaceutical, Shandong Renhetang Pharmaceutical and AdvaCare Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Levamisole Hydrochloride Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Levamisole Hydrochloride Tablets.

Report Scope

The Levamisole Hydrochloride Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Levamisole Hydrochloride Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Levamisole Hydrochloride Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Levamisole Hydrochloride Tablets Market Report

Report Metric Details
Report Name Levamisole Hydrochloride Tablets Market
Segment by Type
  • 25mg/Tablet
  • 50mg/Tablet
Segment by Application
  • Hospital Pharmacy
  • Retail Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Nanjing Baijingyu Pharmaceutical, Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical, Zhejiang Ruixin Pharmaceutical, Guangdong Huanan Pharmaceutical, Guilin Pharmaceutical, Shanxi Taiyuan Pharmaceutical, Guangdong Nanguo Pharmaceutical, Shandong Renhetang Pharmaceutical, AdvaCare Pharma, Connote Healthcare, Glowderma Lab, Janssen Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Levamisole Hydrochloride Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Levamisole Hydrochloride Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Levamisole Hydrochloride Tablets Market report?

Ans: The main players in the Levamisole Hydrochloride Tablets Market are Nanjing Baijingyu Pharmaceutical, Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical, Zhejiang Ruixin Pharmaceutical, Guangdong Huanan Pharmaceutical, Guilin Pharmaceutical, Shanxi Taiyuan Pharmaceutical, Guangdong Nanguo Pharmaceutical, Shandong Renhetang Pharmaceutical, AdvaCare Pharma, Connote Healthcare, Glowderma Lab, Janssen Pharmaceuticals

What are the Application segmentation covered in the Levamisole Hydrochloride Tablets Market report?

Ans: The Applications covered in the Levamisole Hydrochloride Tablets Market report are Hospital Pharmacy, Retail Pharmacy

What are the Type segmentation covered in the Levamisole Hydrochloride Tablets Market report?

Ans: The Types covered in the Levamisole Hydrochloride Tablets Market report are 25mg/Tablet, 50mg/Tablet

1 Levamisole Hydrochloride Tablets Market Overview
1.1 Product Overview and Scope of Levamisole Hydrochloride Tablets
1.2 Levamisole Hydrochloride Tablets Segment by Type
1.2.1 Global Levamisole Hydrochloride Tablets Market Value Comparison by Type (2024-2030)
1.2.2 25mg/Tablet
1.2.3 50mg/Tablet
1.3 Levamisole Hydrochloride Tablets Segment by Application
1.3.1 Global Levamisole Hydrochloride Tablets Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Global Levamisole Hydrochloride Tablets Market Size Estimates and Forecasts
1.4.1 Global Levamisole Hydrochloride Tablets Revenue 2019-2030
1.4.2 Global Levamisole Hydrochloride Tablets Sales 2019-2030
1.4.3 Global Levamisole Hydrochloride Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Levamisole Hydrochloride Tablets Market Competition by Manufacturers
2.1 Global Levamisole Hydrochloride Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Levamisole Hydrochloride Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Levamisole Hydrochloride Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Levamisole Hydrochloride Tablets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Levamisole Hydrochloride Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Levamisole Hydrochloride Tablets, Product Type & Application
2.7 Levamisole Hydrochloride Tablets Market Competitive Situation and Trends
2.7.1 Levamisole Hydrochloride Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Levamisole Hydrochloride Tablets Players Market Share by Revenue
2.7.3 Global Levamisole Hydrochloride Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Levamisole Hydrochloride Tablets Retrospective Market Scenario by Region
3.1 Global Levamisole Hydrochloride Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Levamisole Hydrochloride Tablets Global Levamisole Hydrochloride Tablets Sales by Region: 2019-2030
3.2.1 Global Levamisole Hydrochloride Tablets Sales by Region: 2019-2024
3.2.2 Global Levamisole Hydrochloride Tablets Sales by Region: 2025-2030
3.3 Global Levamisole Hydrochloride Tablets Global Levamisole Hydrochloride Tablets Revenue by Region: 2019-2030
3.3.1 Global Levamisole Hydrochloride Tablets Revenue by Region: 2019-2024
3.3.2 Global Levamisole Hydrochloride Tablets Revenue by Region: 2025-2030
3.4 North America Levamisole Hydrochloride Tablets Market Facts & Figures by Country
3.4.1 North America Levamisole Hydrochloride Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Levamisole Hydrochloride Tablets Sales by Country (2019-2030)
3.4.3 North America Levamisole Hydrochloride Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Levamisole Hydrochloride Tablets Market Facts & Figures by Country
3.5.1 Europe Levamisole Hydrochloride Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Levamisole Hydrochloride Tablets Sales by Country (2019-2030)
3.5.3 Europe Levamisole Hydrochloride Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Levamisole Hydrochloride Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Levamisole Hydrochloride Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Levamisole Hydrochloride Tablets Sales by Country (2019-2030)
3.6.3 Asia Pacific Levamisole Hydrochloride Tablets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Levamisole Hydrochloride Tablets Market Facts & Figures by Country
3.7.1 Latin America Levamisole Hydrochloride Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Levamisole Hydrochloride Tablets Sales by Country (2019-2030)
3.7.3 Latin America Levamisole Hydrochloride Tablets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Levamisole Hydrochloride Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Levamisole Hydrochloride Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Levamisole Hydrochloride Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Levamisole Hydrochloride Tablets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Levamisole Hydrochloride Tablets Sales by Type (2019-2030)
4.1.1 Global Levamisole Hydrochloride Tablets Sales by Type (2019-2024)
4.1.2 Global Levamisole Hydrochloride Tablets Sales by Type (2025-2030)
4.1.3 Global Levamisole Hydrochloride Tablets Sales Market Share by Type (2019-2030)
4.2 Global Levamisole Hydrochloride Tablets Revenue by Type (2019-2030)
4.2.1 Global Levamisole Hydrochloride Tablets Revenue by Type (2019-2024)
4.2.2 Global Levamisole Hydrochloride Tablets Revenue by Type (2025-2030)
4.2.3 Global Levamisole Hydrochloride Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Levamisole Hydrochloride Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Levamisole Hydrochloride Tablets Sales by Application (2019-2030)
5.1.1 Global Levamisole Hydrochloride Tablets Sales by Application (2019-2024)
5.1.2 Global Levamisole Hydrochloride Tablets Sales by Application (2025-2030)
5.1.3 Global Levamisole Hydrochloride Tablets Sales Market Share by Application (2019-2030)
5.2 Global Levamisole Hydrochloride Tablets Revenue by Application (2019-2030)
5.2.1 Global Levamisole Hydrochloride Tablets Revenue by Application (2019-2024)
5.2.2 Global Levamisole Hydrochloride Tablets Revenue by Application (2025-2030)
5.2.3 Global Levamisole Hydrochloride Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Levamisole Hydrochloride Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Nanjing Baijingyu Pharmaceutical
6.1.1 Nanjing Baijingyu Pharmaceutical Corporation Information
6.1.2 Nanjing Baijingyu Pharmaceutical Description and Business Overview
6.1.3 Nanjing Baijingyu Pharmaceutical Levamisole Hydrochloride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Nanjing Baijingyu Pharmaceutical Levamisole Hydrochloride Tablets Product Portfolio
6.1.5 Nanjing Baijingyu Pharmaceutical Recent Developments/Updates
6.2 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical
6.2.1 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Corporation Information
6.2.2 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Description and Business Overview
6.2.3 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Levamisole Hydrochloride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Levamisole Hydrochloride Tablets Product Portfolio
6.2.5 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Recent Developments/Updates
6.3 Zhejiang Ruixin Pharmaceutical
6.3.1 Zhejiang Ruixin Pharmaceutical Corporation Information
6.3.2 Zhejiang Ruixin Pharmaceutical Description and Business Overview
6.3.3 Zhejiang Ruixin Pharmaceutical Levamisole Hydrochloride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zhejiang Ruixin Pharmaceutical Levamisole Hydrochloride Tablets Product Portfolio
6.3.5 Zhejiang Ruixin Pharmaceutical Recent Developments/Updates
6.4 Guangdong Huanan Pharmaceutical
6.4.1 Guangdong Huanan Pharmaceutical Corporation Information
6.4.2 Guangdong Huanan Pharmaceutical Description and Business Overview
6.4.3 Guangdong Huanan Pharmaceutical Levamisole Hydrochloride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guangdong Huanan Pharmaceutical Levamisole Hydrochloride Tablets Product Portfolio
6.4.5 Guangdong Huanan Pharmaceutical Recent Developments/Updates
6.5 Guilin Pharmaceutical
6.5.1 Guilin Pharmaceutical Corporation Information
6.5.2 Guilin Pharmaceutical Description and Business Overview
6.5.3 Guilin Pharmaceutical Levamisole Hydrochloride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Guilin Pharmaceutical Levamisole Hydrochloride Tablets Product Portfolio
6.5.5 Guilin Pharmaceutical Recent Developments/Updates
6.6 Shanxi Taiyuan Pharmaceutical
6.6.1 Shanxi Taiyuan Pharmaceutical Corporation Information
6.6.2 Shanxi Taiyuan Pharmaceutical Description and Business Overview
6.6.3 Shanxi Taiyuan Pharmaceutical Levamisole Hydrochloride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shanxi Taiyuan Pharmaceutical Levamisole Hydrochloride Tablets Product Portfolio
6.6.5 Shanxi Taiyuan Pharmaceutical Recent Developments/Updates
6.7 Guangdong Nanguo Pharmaceutical
6.6.1 Guangdong Nanguo Pharmaceutical Corporation Information
6.6.2 Guangdong Nanguo Pharmaceutical Description and Business Overview
6.6.3 Guangdong Nanguo Pharmaceutical Levamisole Hydrochloride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guangdong Nanguo Pharmaceutical Levamisole Hydrochloride Tablets Product Portfolio
6.7.5 Guangdong Nanguo Pharmaceutical Recent Developments/Updates
6.8 Shandong Renhetang Pharmaceutical
6.8.1 Shandong Renhetang Pharmaceutical Corporation Information
6.8.2 Shandong Renhetang Pharmaceutical Description and Business Overview
6.8.3 Shandong Renhetang Pharmaceutical Levamisole Hydrochloride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shandong Renhetang Pharmaceutical Levamisole Hydrochloride Tablets Product Portfolio
6.8.5 Shandong Renhetang Pharmaceutical Recent Developments/Updates
6.9 AdvaCare Pharma
6.9.1 AdvaCare Pharma Corporation Information
6.9.2 AdvaCare Pharma Description and Business Overview
6.9.3 AdvaCare Pharma Levamisole Hydrochloride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AdvaCare Pharma Levamisole Hydrochloride Tablets Product Portfolio
6.9.5 AdvaCare Pharma Recent Developments/Updates
6.10 Connote Healthcare
6.10.1 Connote Healthcare Corporation Information
6.10.2 Connote Healthcare Description and Business Overview
6.10.3 Connote Healthcare Levamisole Hydrochloride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Connote Healthcare Levamisole Hydrochloride Tablets Product Portfolio
6.10.5 Connote Healthcare Recent Developments/Updates
6.11 Glowderma Lab
6.11.1 Glowderma Lab Corporation Information
6.11.2 Glowderma Lab Levamisole Hydrochloride Tablets Description and Business Overview
6.11.3 Glowderma Lab Levamisole Hydrochloride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Glowderma Lab Levamisole Hydrochloride Tablets Product Portfolio
6.11.5 Glowderma Lab Recent Developments/Updates
6.12 Janssen Pharmaceuticals
6.12.1 Janssen Pharmaceuticals Corporation Information
6.12.2 Janssen Pharmaceuticals Levamisole Hydrochloride Tablets Description and Business Overview
6.12.3 Janssen Pharmaceuticals Levamisole Hydrochloride Tablets Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Janssen Pharmaceuticals Levamisole Hydrochloride Tablets Product Portfolio
6.12.5 Janssen Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Levamisole Hydrochloride Tablets Industry Chain Analysis
7.2 Levamisole Hydrochloride Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Levamisole Hydrochloride Tablets Production Mode & Process
7.4 Levamisole Hydrochloride Tablets Sales and Marketing
7.4.1 Levamisole Hydrochloride Tablets Sales Channels
7.4.2 Levamisole Hydrochloride Tablets Distributors
7.5 Levamisole Hydrochloride Tablets Customers
8 Levamisole Hydrochloride Tablets Market Dynamics
8.1 Levamisole Hydrochloride Tablets Industry Trends
8.2 Levamisole Hydrochloride Tablets Market Drivers
8.3 Levamisole Hydrochloride Tablets Market Challenges
8.4 Levamisole Hydrochloride Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Levamisole Hydrochloride Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Levamisole Hydrochloride Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Levamisole Hydrochloride Tablets Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Levamisole Hydrochloride Tablets Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Levamisole Hydrochloride Tablets Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Levamisole Hydrochloride Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Levamisole Hydrochloride Tablets Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Levamisole Hydrochloride Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Levamisole Hydrochloride Tablets, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Levamisole Hydrochloride Tablets, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Levamisole Hydrochloride Tablets, Product Type & Application
    Table 12. Global Key Manufacturers of Levamisole Hydrochloride Tablets, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Levamisole Hydrochloride Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Levamisole Hydrochloride Tablets as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Levamisole Hydrochloride Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Levamisole Hydrochloride Tablets Sales by Region (2019-2024) & (K Units)
    Table 18. Global Levamisole Hydrochloride Tablets Sales Market Share by Region (2019-2024)
    Table 19. Global Levamisole Hydrochloride Tablets Sales by Region (2025-2030) & (K Units)
    Table 20. Global Levamisole Hydrochloride Tablets Sales Market Share by Region (2025-2030)
    Table 21. Global Levamisole Hydrochloride Tablets Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Levamisole Hydrochloride Tablets Revenue Market Share by Region (2019-2024)
    Table 23. Global Levamisole Hydrochloride Tablets Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Levamisole Hydrochloride Tablets Revenue Market Share by Region (2025-2030)
    Table 25. North America Levamisole Hydrochloride Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Levamisole Hydrochloride Tablets Sales by Country (2019-2024) & (K Units)
    Table 27. North America Levamisole Hydrochloride Tablets Sales by Country (2025-2030) & (K Units)
    Table 28. North America Levamisole Hydrochloride Tablets Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Levamisole Hydrochloride Tablets Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Levamisole Hydrochloride Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Levamisole Hydrochloride Tablets Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Levamisole Hydrochloride Tablets Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Levamisole Hydrochloride Tablets Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Levamisole Hydrochloride Tablets Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Levamisole Hydrochloride Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Levamisole Hydrochloride Tablets Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Levamisole Hydrochloride Tablets Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Levamisole Hydrochloride Tablets Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Levamisole Hydrochloride Tablets Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Levamisole Hydrochloride Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Levamisole Hydrochloride Tablets Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Levamisole Hydrochloride Tablets Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Levamisole Hydrochloride Tablets Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Levamisole Hydrochloride Tablets Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Levamisole Hydrochloride Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Levamisole Hydrochloride Tablets Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Levamisole Hydrochloride Tablets Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Levamisole Hydrochloride Tablets Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Levamisole Hydrochloride Tablets Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Levamisole Hydrochloride Tablets Sales (K Units) by Type (2019-2024)
    Table 51. Global Levamisole Hydrochloride Tablets Sales (K Units) by Type (2025-2030)
    Table 52. Global Levamisole Hydrochloride Tablets Sales Market Share by Type (2019-2024)
    Table 53. Global Levamisole Hydrochloride Tablets Sales Market Share by Type (2025-2030)
    Table 54. Global Levamisole Hydrochloride Tablets Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Levamisole Hydrochloride Tablets Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Levamisole Hydrochloride Tablets Revenue Market Share by Type (2019-2024)
    Table 57. Global Levamisole Hydrochloride Tablets Revenue Market Share by Type (2025-2030)
    Table 58. Global Levamisole Hydrochloride Tablets Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Levamisole Hydrochloride Tablets Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Levamisole Hydrochloride Tablets Sales (K Units) by Application (2019-2024)
    Table 61. Global Levamisole Hydrochloride Tablets Sales (K Units) by Application (2025-2030)
    Table 62. Global Levamisole Hydrochloride Tablets Sales Market Share by Application (2019-2024)
    Table 63. Global Levamisole Hydrochloride Tablets Sales Market Share by Application (2025-2030)
    Table 64. Global Levamisole Hydrochloride Tablets Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Levamisole Hydrochloride Tablets Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Levamisole Hydrochloride Tablets Revenue Market Share by Application (2019-2024)
    Table 67. Global Levamisole Hydrochloride Tablets Revenue Market Share by Application (2025-2030)
    Table 68. Global Levamisole Hydrochloride Tablets Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Levamisole Hydrochloride Tablets Price (US$/Unit) by Application (2025-2030)
    Table 70. Nanjing Baijingyu Pharmaceutical Corporation Information
    Table 71. Nanjing Baijingyu Pharmaceutical Description and Business Overview
    Table 72. Nanjing Baijingyu Pharmaceutical Levamisole Hydrochloride Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Nanjing Baijingyu Pharmaceutical Levamisole Hydrochloride Tablets Product
    Table 74. Nanjing Baijingyu Pharmaceutical Recent Developments/Updates
    Table 75. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Corporation Information
    Table 76. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Description and Business Overview
    Table 77. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Levamisole Hydrochloride Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Levamisole Hydrochloride Tablets Product
    Table 79. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Recent Developments/Updates
    Table 80. Zhejiang Ruixin Pharmaceutical Corporation Information
    Table 81. Zhejiang Ruixin Pharmaceutical Description and Business Overview
    Table 82. Zhejiang Ruixin Pharmaceutical Levamisole Hydrochloride Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Zhejiang Ruixin Pharmaceutical Levamisole Hydrochloride Tablets Product
    Table 84. Zhejiang Ruixin Pharmaceutical Recent Developments/Updates
    Table 85. Guangdong Huanan Pharmaceutical Corporation Information
    Table 86. Guangdong Huanan Pharmaceutical Description and Business Overview
    Table 87. Guangdong Huanan Pharmaceutical Levamisole Hydrochloride Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Guangdong Huanan Pharmaceutical Levamisole Hydrochloride Tablets Product
    Table 89. Guangdong Huanan Pharmaceutical Recent Developments/Updates
    Table 90. Guilin Pharmaceutical Corporation Information
    Table 91. Guilin Pharmaceutical Description and Business Overview
    Table 92. Guilin Pharmaceutical Levamisole Hydrochloride Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Guilin Pharmaceutical Levamisole Hydrochloride Tablets Product
    Table 94. Guilin Pharmaceutical Recent Developments/Updates
    Table 95. Shanxi Taiyuan Pharmaceutical Corporation Information
    Table 96. Shanxi Taiyuan Pharmaceutical Description and Business Overview
    Table 97. Shanxi Taiyuan Pharmaceutical Levamisole Hydrochloride Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Shanxi Taiyuan Pharmaceutical Levamisole Hydrochloride Tablets Product
    Table 99. Shanxi Taiyuan Pharmaceutical Recent Developments/Updates
    Table 100. Guangdong Nanguo Pharmaceutical Corporation Information
    Table 101. Guangdong Nanguo Pharmaceutical Description and Business Overview
    Table 102. Guangdong Nanguo Pharmaceutical Levamisole Hydrochloride Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Guangdong Nanguo Pharmaceutical Levamisole Hydrochloride Tablets Product
    Table 104. Guangdong Nanguo Pharmaceutical Recent Developments/Updates
    Table 105. Shandong Renhetang Pharmaceutical Corporation Information
    Table 106. Shandong Renhetang Pharmaceutical Description and Business Overview
    Table 107. Shandong Renhetang Pharmaceutical Levamisole Hydrochloride Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Shandong Renhetang Pharmaceutical Levamisole Hydrochloride Tablets Product
    Table 109. Shandong Renhetang Pharmaceutical Recent Developments/Updates
    Table 110. AdvaCare Pharma Corporation Information
    Table 111. AdvaCare Pharma Description and Business Overview
    Table 112. AdvaCare Pharma Levamisole Hydrochloride Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. AdvaCare Pharma Levamisole Hydrochloride Tablets Product
    Table 114. AdvaCare Pharma Recent Developments/Updates
    Table 115. Connote Healthcare Corporation Information
    Table 116. Connote Healthcare Description and Business Overview
    Table 117. Connote Healthcare Levamisole Hydrochloride Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Connote Healthcare Levamisole Hydrochloride Tablets Product
    Table 119. Connote Healthcare Recent Developments/Updates
    Table 120. Glowderma Lab Corporation Information
    Table 121. Glowderma Lab Description and Business Overview
    Table 122. Glowderma Lab Levamisole Hydrochloride Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Glowderma Lab Levamisole Hydrochloride Tablets Product
    Table 124. Glowderma Lab Recent Developments/Updates
    Table 125. Janssen Pharmaceuticals Corporation Information
    Table 126. Janssen Pharmaceuticals Description and Business Overview
    Table 127. Janssen Pharmaceuticals Levamisole Hydrochloride Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Janssen Pharmaceuticals Levamisole Hydrochloride Tablets Product
    Table 129. Janssen Pharmaceuticals Recent Developments/Updates
    Table 130. Key Raw Materials Lists
    Table 131. Raw Materials Key Suppliers Lists
    Table 132. Levamisole Hydrochloride Tablets Distributors List
    Table 133. Levamisole Hydrochloride Tablets Customers List
    Table 134. Levamisole Hydrochloride Tablets Market Trends
    Table 135. Levamisole Hydrochloride Tablets Market Drivers
    Table 136. Levamisole Hydrochloride Tablets Market Challenges
    Table 137. Levamisole Hydrochloride Tablets Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Levamisole Hydrochloride Tablets
    Figure 2. Global Levamisole Hydrochloride Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Levamisole Hydrochloride Tablets Market Share by Type in 2023 & 2030
    Figure 4. 25mg/Tablet Product Picture
    Figure 5. 50mg/Tablet Product Picture
    Figure 6. Global Levamisole Hydrochloride Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Levamisole Hydrochloride Tablets Market Share by Application in 2023 & 2030
    Figure 8. Hospital Pharmacy
    Figure 9. Retail Pharmacy
    Figure 10. Global Levamisole Hydrochloride Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Levamisole Hydrochloride Tablets Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Levamisole Hydrochloride Tablets Sales (2019-2030) & (K Units)
    Figure 13. Global Levamisole Hydrochloride Tablets Average Price (US$/Unit) & (2019-2030)
    Figure 14. Levamisole Hydrochloride Tablets Report Years Considered
    Figure 15. Levamisole Hydrochloride Tablets Sales Share by Manufacturers in 2023
    Figure 16. Global Levamisole Hydrochloride Tablets Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Levamisole Hydrochloride Tablets Players: Market Share by Revenue in 2023
    Figure 18. Levamisole Hydrochloride Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Levamisole Hydrochloride Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Levamisole Hydrochloride Tablets Sales Market Share by Country (2019-2030)
    Figure 21. North America Levamisole Hydrochloride Tablets Revenue Market Share by Country (2019-2030)
    Figure 22. United States Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Levamisole Hydrochloride Tablets Sales Market Share by Country (2019-2030)
    Figure 25. Europe Levamisole Hydrochloride Tablets Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Levamisole Hydrochloride Tablets Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Levamisole Hydrochloride Tablets Revenue Market Share by Region (2019-2030)
    Figure 33. China Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. China Taiwan Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Latin America Levamisole Hydrochloride Tablets Sales Market Share by Country (2019-2030)
    Figure 43. Latin America Levamisole Hydrochloride Tablets Revenue Market Share by Country (2019-2030)
    Figure 44. Mexico Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Brazil Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Argentina Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Levamisole Hydrochloride Tablets Sales Market Share by Country (2019-2030)
    Figure 48. Middle East & Africa Levamisole Hydrochloride Tablets Revenue Market Share by Country (2019-2030)
    Figure 49. Turkey Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Saudi Arabia Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. UAE Levamisole Hydrochloride Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Global Sales Market Share of Levamisole Hydrochloride Tablets by Type (2019-2030)
    Figure 53. Global Revenue Market Share of Levamisole Hydrochloride Tablets by Type (2019-2030)
    Figure 54. Global Levamisole Hydrochloride Tablets Price (US$/Unit) by Type (2019-2030)
    Figure 55. Global Sales Market Share of Levamisole Hydrochloride Tablets by Application (2019-2030)
    Figure 56. Global Revenue Market Share of Levamisole Hydrochloride Tablets by Application (2019-2030)
    Figure 57. Global Levamisole Hydrochloride Tablets Price (US$/Unit) by Application (2019-2030)
    Figure 58. Levamisole Hydrochloride Tablets Value Chain
    Figure 59. Levamisole Hydrochloride Tablets Production Process
    Figure 60. Channels of Distribution (Direct Vs Distribution)
    Figure 61. Distributors Profiles
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart